AVROBIO Inc
Change company Symbol lookup
Select an option...
AVRO AVROBIO Inc
BBW Build-A-Bear Workshop Inc
GWPH GW Pharmaceuticals PLC
LMT Lockheed Martin Corp
TELL Tellurian Inc
PFE Pfizer Inc
AGNC Agnc Investment Corp
AAPL Apple Inc
GRTYA Guaranty Corp
SATS EchoStar Corp
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

AVROBIO, Inc. is a clinical-stage gene therapy company. The Company is focused on developing curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose. Its gene therapies employ hematopoietic stem cells that are extracted from the patient and then modified with lentiviral vectors to insert a functional copy of the gene that is defective in the target disease. Its product pipeline includes AVR-RD-01, AVR-RD-02, AVR-RD-03 and AVR-RD-04. The Company is developing AVR-RD-01 for the treatment of Fabry disease. AVR-RD-02 is the Company’s gene therapy for Gaucher disease. AVR-RD-03 is being developed for the treatment of Pompe disease. The Company is developing AVR-RD-04 for the treatment of patients with cystinosis.

Postmarket

Last Trade
Delayed
$12.95
-0.32 (-2.41%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$13.27
Day's Change
-0.12 (-0.90%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
13.53
Day's Low
12.86
Volume
(Light)
Volume:
355,177

10-day average volume:
631,298
355,177
  • Prev Close
    13.39
  • Today's Open
    13.43
  • Day's Range
    12.86-13.53
  • Avg Vol (10-day)
    631.3K
  • Last (time)
    3:59p ET 12/04/20
  • Last (size)
    39
  • 52-Wk Range
    9.76 - 29.32
    LowHigh
  • (02/12/20 - 03/17/20)
    35.96%
  • 99.9%
  • Market Cap
    550.1M
  • Shares Outstanding
    41.5M
  • -3.29
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 91.24
  • (% of float 11/15/20)
    8.64

Latest News

December 04, 2020
4:00 am ET
BusinessWire
November 24, 2020
1:19 pm ET
BusinessWire
November 19, 2020
7:06 pm ET
BusinessWire
1:09 pm ET
BusinessWire
November 17, 2020
4:00 am ET
BusinessWire
November 06, 2020
4:00 am ET
BusinessWire
November 05, 2020
4:00 am ET
BusinessWire
October 29, 2020
4:00 am ET
BusinessWire
October 26, 2020
7:00 am ET
BusinessWire
October 21, 2020
7:00 am ET
BusinessWire
October 06, 2020
7:00 am ET
BusinessWire
October 05, 2020
7:00 am ET
BusinessWire
September 28, 2020
7:00 am ET
BusinessWire
September 25, 2020
7:00 am ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.